|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.33 USD | -10.04% |
|
-0.21% | +15.92% |
| 04-15 | Top Premarket Decliners | MT |
| 01-30 | Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Universe Pharmaceuticals INC reported earnings results for the half year ended March 31, 2022. For the half year, the company reported sales was USD 24.2 million compared to USD 24.29 million a year ago. Net income was USD 1.73 million compared to USD 7.15 million a year ago.
Basic earnings per share from continuing operations was USD 0.08 compared to USD 0.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.92% | 8.45M | |
| +41.06% | 6.19B | |
| -15.95% | 4.48B | |
| +6.36% | 3.29B | |
| -11.34% | 3.12B | |
| -3.12% | 2.5B | |
| +45.41% | 1.94B | |
| -7.74% | 1.68B | |
| -0.67% | 1.64B | |
| -11.32% | 1.56B |
UNIVERSE PHARMACEUTICALS INC 
